Global medical technology company Smith+Nephew (LSE: SN, NYSE: SNN) has released new guidance for the use of single-use negative pressure wound therapy (sNPWT) in closed surgical incisions. Developed by expert clinicians, the consensus-based guidance includes practical clinical practice recommendations specifically tailored for Germany. The guidance has been published in the esteemed journal of surgery Die Chirurgie. Smith+Nephew, a leader in sNPWT and the maker of the PICO™7 sNPWT system, supported the development of this new German consensus.